SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 119.90   1.86 (+1.58%) Volume: 473.63k 4:00 PM EDT 4-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)13305/08/2020
8-KCurrent report pursuant to Section 13 or 15(d)1605/06/2020
4Statement of changes in beneficial ownership of securities104/24/2020
4Statement of changes in beneficial ownership of securities104/24/2020
4Statement of changes in beneficial ownership of securities104/24/2020
DEF 14AOther definitive proxy statements5304/24/2020
DEFA14AAdditional proxy soliciting materials - definitive304/24/2020
8-KCurrent report pursuant to Section 13 or 15(d)404/07/2020
8-KCurrent report pursuant to Section 13 or 15(d)404/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)704/02/2020
4Statement of changes in beneficial ownership of securities103/13/2020
4Statement of changes in beneficial ownership of securities102/27/2020
10-KAnnual report pursuant to Section 13 or 15(d)19102/27/2020
4Statement of changes in beneficial ownership of securities102/18/2020
4Statement of changes in beneficial ownership of securities102/18/2020
<<
First
<
Prev
123456789101112131415